Breaking
TRAKP Deputy Chairman Fatma Betül Sayan Kaya's claim that she and her husband earned more than 2 billion TL in 5 months, and Melis Sandal's claim that she withdrew 11 billion TL from funds liquidated by the CMB in 3 months are on the agenda.RUThe Russian national team leads 2:0 against Iran after the first half, both goals were scored by GolovinDEManchester City found guilty of financial breaches – appeal announcedFRLyon: more than a million euros in cinema equipment stolen, a suspect arrestedSENew satellite images show widespread destruction in Gaza after Israeli bombingsARIsraeli settlers attack a Palestinian family and burn their house again after they returnCRYPTO-ENBitwise launches first US spot NEAR ETF on NYSE ArcaUSOpenAI launches Dots, a new personal agentic assistant powered by GPT-6 AstraFRStellantis announces production stoppages in October at four French factoriesRUThe developer "Samolet" for the second time committed a technical default on bonds worth 2.5 billion rublesTRAKP Deputy Chairman Fatma Betül Sayan Kaya's claim that she and her husband earned more than 2 billion TL in 5 months, and Melis Sandal's claim that she withdrew 11 billion TL from funds liquidated by the CMB in 3 months are on the agenda.RUThe Russian national team leads 2:0 against Iran after the first half, both goals were scored by GolovinDEManchester City found guilty of financial breaches – appeal announcedFRLyon: more than a million euros in cinema equipment stolen, a suspect arrestedSENew satellite images show widespread destruction in Gaza after Israeli bombingsARIsraeli settlers attack a Palestinian family and burn their house again after they returnCRYPTO-ENBitwise launches first US spot NEAR ETF on NYSE ArcaUSOpenAI launches Dots, a new personal agentic assistant powered by GPT-6 AstraFRStellantis announces production stoppages in October at four French factoriesRUThe developer "Samolet" for the second time committed a technical default on bonds worth 2.5 billion rubles
BackIran negotiations briefly support DAX, Anthropic is aiming for a market value of $2 trillion
Iran negotiations briefly support DAX, Anthropic is aiming for a market value of $2 trillion
Developing
Tagesschau Wirtschaft42 minutes agoBusiness2 min readGermanyView original

Iran negotiations briefly support DAX, Anthropic is aiming for a market value of $2 trillion

Quick Look

  • Hopes for a diplomatic solution to the Iran conflict briefly supported the German stock market, with the DAX closing up 0.1 percent at 25,399 points.
  • At the same time, the AI ​​developer Anthropic is aiming for a market capitalization of over two trillion dollars in its planned US IPO, despite high losses.
  • Evonik rejected a takeover offer from BASF, while Hornbach was asked for strong half-year figures and Renk continued to perform poorly.

AI-generated summary

Why It Matters

The Iran conflict has been preoccupying the international markets for a long time, with diplomatic negotiations always giving hope for a solution. At the same time, competition in the AI ​​sector is developing dynamically, with companies like Anthropic accepting high losses in order to secure growth and market position. In the German industrial context, companies like Evonik and Hornbach show different developments depending on strategic decisions and demand conditions.

Font size

New hopes for a diplomatic solution to the Iran conflict continue to support the German stock market. In the morning, Iran's foreign minister spoke of ongoing negotiations with the USA, this time about the Gulf state of Qatar.

The DAX then turned upwards while oil prices fell. By the close of trading, however, prices had collapsed again and the leading German index closed with a modest increase of 0.1 percent at 25,399 points. At the beginning of the week, the DAX ended trading slightly weaker at 25,374 points.

“In the absence of stimulus, the DAX is currently just standing still,” commented Jochen Stanzl, market observer at Consorsbank. "While oil prices are rising again, there is still hope for a diplomatic agreement. The reasons for and the reasons against buying shares are currently more or less canceling each other out."

In the morning, the oil price for North Sea Brent was still above $100 per barrel, but then fell back to below $97. However, there was no concrete progress in negotiations in the Iran conflict. Therefore, the US stock exchanges started the day again with slight discounts.

The AI ​​developer Anthropic is aiming for a market capitalization of more than two trillion dollars in its planned US IPO. This emerges from the issue prospectus, which the Reuters news agency was able to see. Anthropic would thus end up in seventh place in the ranking of the most valuable companies on the stock market.

However, Anthropic is buying its rapid growth with high losses. Last year, sales rose to around $4.6 billion, but losses climbed to a similar extent to $42 billion. The lion's share of this is due to write-downs in connection with previous financing rounds. The operating loss was still eight billion dollars.

One reason: the rising costs of computing capacity needed to train and operate AI. At the same time, out-of-control AI models that penetrate third-party IT systems repeatedly make headlines. This has sparked a debate about whether this technology poses an existential threat to humanity. Just today, competitor OpenAI suspended its new model due to security concerns.

Evonik shares were only slightly up today. According to the Financial Times (FT), the specialty chemicals company has rejected a takeover offer from BASF. The industry leader offered 22.15 euros per Evonik paper, the FT wrote on Monday evening, citing people familiar with the matter. Evonik confirmed on Friday that BASF had approached the company without obligation. Since then, Evonik shares have increased by just over ten percent.

In the SDAX, the shares of the DIY store group Hornbach Holding were in demand for strong half-year figures. Sales climbed by six percent to 3.8 billion euros in the first six months of the 2026/27 financial year. The adjusted operating result (EBIT) increased by almost five percent to 285.6 million euros.

The main reason for this was the strong demand for seasonal products such as air conditioning units, but also items for shading and irrigation. Hornbach said that they were able to gain market share in Germany and other European countries. Despite the ongoing geopolitical uncertainties, the group confirmed its forecast for the full year.

Defense stocks performed weakly again. Renk's losses stood out again. The gear manufacturer costs as much on the stock market again as it did in spring 2025. Yesterday, JPMorgan analyst David Perry justified a price target reduction for Renk by saying that the operating result in the third quarter could be “somewhat disappointing”. At 62 euros, he still sees 64 percent room for improvement for the share and accordingly stuck to his "overweight" recommendation. Renk wants to present his quarterly report on November 5th.

What to Watch

AI outlook — possibilities, not facts

  • The DAX will continue to fluctuate in the coming days, depending on progress in the Iran negotiations.

    Likely · Within days

  • Anthropic will go ahead with its planned US IPO despite high losses.

    Possible · Within months

  • Evonik will maintain its independence from BASF unless a significantly improved offer comes along.

    Likely · Within weeks

Open Questions

  • When exactly will the Iran negotiations lead to a result?
  • How will Anthropic justify its high losses despite its planned billion-dollar valuation?
  • Will BASF make a new takeover offer for Evonik?
  • How will demand for seasonal products at Hornbach develop in the second half of the year?

Related Topics

This article was originally published by Tagesschau Wirtschaft.

Related Stories

Biontech is closing plants in Marburg, Tübingen and Idar-Oberstein - end of a pandemic-related production phase
Developing·

Biontech is closing plants in Marburg, Tübingen and Idar-Oberstein - end of a pandemic-related production phase

Biontech announces the closure of its production sites in Marburg, Tübingen and Idar-Oberstein. The factories had contributed to Comirnaty's vaccine production during the pandemic. The withdrawal comes as the company transitions away from dependence on the Covid vaccine and towards new products, particularly in cancer medicine. The step is a loss for Marburg and its employees, and a warning signal for Germany as a pharmaceutical location.

FAZ
2 min read
Federal Employment Agency presents September labor market figures – only moderate autumn recovery expected
Developing·

Federal Employment Agency presents September labor market figures – only moderate autumn recovery expected

The Federal Employment Agency in Nuremberg presents its labor market statistics for September. Due to the usual seasonal decline in unemployment, only a moderate autumn recovery is expected. It remains unclear whether the number of unemployed will fall below three million. In the long term, labor market researchers see rays of hope in a more stable economy and government stimulus packages despite the shrinking workforce potential.

Die Zeit
1 min read
More on this topicIran